Previous Close | 5.10 |
Open | 5.12 |
Bid | 5.13 x 200 |
Ask | 5.19 x 100 |
Day's Range | 5.04 - 5.18 |
52 Week Range | 4.71 - 12.43 |
Volume | |
Avg. Volume | 2,160,108 |
Market Cap | 737.978M |
Beta (5Y Monthly) | 1.38 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript May 2, 2024 Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17. AUPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Aurinia […]
Aurinia (AUPH) delivered earnings and revenue surprises of 82.35% and 8.65%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
With the business potentially at an important milestone, we thought we'd take a closer look at Aurinia Pharmaceuticals...